Monitoring of CO2 during percutaneous dilatational tracheostomy by transcutaneous measurement

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011004

Enrollment

Registered

2016-09-20

Start date

2016-09-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.1 J80

Interventions

Group 1: Observation: measurement of percutaneous CO2 during ventilation with 6 ml/kg ideal bodyweight during percutaneous dilational tracheostomy Group 2: Intervention: measurement of percutaneous CO

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: intubated patients undergoing percutaneous dilational tracheostomy with a positive endexpiratory pressure of less than 15 cmH2O; sufficient oxygenation and pH>7.20

Exclusion criteria

Exclusion criteria: pH<7.20, Percutaneous dilational tracheostomy not feasible, technical impossibility of percutaneous CO2 measurement, difference of percutaneous to arterial CO2 of more than 10%

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the measurement of the increase of CO2 by means of percutaneous measurement (SenTec Monitoring System, Switzerland). This values are validated by arterial CO2 measurement in blood gas analysis.	—

Secondary

Measure	Time frame
Increase of CO2 depending on the size of the tube.	—

Countries

Germany

Contacts

Public ContactMichaela Ludmilla Merten

Lungenklinik Köln-Merheim

mertenm@kliniken-koeln.de0221-890718387

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 20, 2026